The treatment of classical hemophilia with factor 8 concentrates.
作者信息
Waterbury L, Frenkel E P
出版信息
Clin Anesth. 1968;3:288-97.
PMID:4902367
Abstract
摘要
相似文献
1
The treatment of classical hemophilia with factor 8 concentrates.
Clin Anesth. 1968;3:288-97.
2
[in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
Z Gesamte Inn Med. 1973 Oct 15;28(20):608-14.
3
4
Clearance of cryoprecipitated factor VIII in canine hemophilia A.犬血友病A中冷沉淀凝血因子VIII的清除率
Am J Vet Res. 1975 Apr;36(4 Pt.1):367-70.
5
[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].用新型抗血友病因子“AHF SRK（人源）”治疗甲型血友病。与抗血友病球蛋白AHG SRK的比较
Schweiz Med Wochenschr. 1971 Dec 18;101(50):1831-8.
6
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
JAMA. 1969 Jun 9;208(10):1853-6.
7
Cryoprecipitate therapy in haemophilia.
Scott Med J. 1969 Jan;14(1):1-9. doi: 10.1177/003693306901400101.
8
[Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
Nouv Rev Fr Hematol. 1972 Mar-Apr;12(2):241-9.
9
[Hemostatic management in hemophilia A. Usefulness of APTT and TEG as a method for monitoring Factor VIII concentrates].
Shoni Shikagaku Zasshi. 1985;23(3):760-8.
10
Acquired circulating anticoagulants in hemophilia A.
N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.
Zotero 插件